Tonix Pharmaceuticals (TNXP) Q4 2025 Earnings

10NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-18.5
-13.26
-8.01
-2.77

Details

Expected EPS
-3.585
Actual EPS
-3.59
Surprise EPS
-0
Surprise Percent
+0.14%

Description

Tonix Pharmaceuticals (TNXP) has reported earnings of -3.59 per share for Q4 2025.

0 Comments

Share your thoughts